» Articles » PMID: 38288085

Editorial: Clinical Phytopharmacology

Overview
Journal Front Pharmacol
Date 2024 Jan 30
PMID 38288085
Authors
Affiliations
Soon will be listed here.
Citing Articles

The Introduction of the Global Traditional, Complementary, and Integrative Healthcare (TCIH) Research Agenda on Antimicrobial Resistance and Its Added Value to the WHO and the WHO/FAO/UNEP/WOAH 2023 Research Agendas on Antimicrobial Resistance.

Baars E, Weiermayer P, Szoke H, van der Werf E Antibiotics (Basel). 2025; 14(1).

PMID: 39858387 PMC: 11762681. DOI: 10.3390/antibiotics14010102.


Isorhamnetin: what is the evidence for its antitumor potential and beyond?.

Lei J, Yang J, Bao C, Lu F, Wu Q, Wu Z Front Pharmacol. 2024; 15:1309178.

PMID: 38650631 PMC: 11033395. DOI: 10.3389/fphar.2024.1309178.

References
1.
Chattopadhyay K, Kapoor N, Heinrich M, Mitra A, Mittal M, Lewis S . Development process of a clinical guideline to manage type 2 diabetes in adults by Ayurvedic practitioners. Front Med (Lausanne). 2023; 10:1043715. PMC: 9922832. DOI: 10.3389/fmed.2023.1043715. View

2.
Gagnier J, Boon H, Rochon P, Moher D, Barnes J, Bombardier C . Recommendations for reporting randomized controlled trials of herbal interventions: Explanation and elaboration. J Clin Epidemiol. 2006; 59(11):1134-49. DOI: 10.1016/j.jclinepi.2005.12.020. View

3.
Schulz K, Altman D, Moher D . CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010; 340:c332. PMC: 2844940. DOI: 10.1136/bmj.c332. View

4.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N . Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2019; 157:107843. DOI: 10.1016/j.diabres.2019.107843. View

5.
Chattopadhyay K, Wang H, Kaur J, Nalbant G, Almaqhawi A, Kundakci B . Effectiveness and Safety of Ayurvedic Medicines in Type 2 Diabetes Mellitus Management: A Systematic Review and Meta-Analysis. Front Pharmacol. 2022; 13:821810. PMC: 9213670. DOI: 10.3389/fphar.2022.821810. View